- Illumina to acquire proteomics company SomaLogic in $425 million all cash deal
- Novo terminates agreement with Hims & Hers to sell weight-loss drug
- Axolotls may hold the key to human organ regeneration: US researchers
- ‘Menstrual tracking data being used to control people’s reproductive lives’
- Novo Nordisk’s obesity drug CagriSema cuts weight by 23%
- Madrigal’s therapy to treat MASH in adults gets EU’s initial nod
- Supernus Pharma to acquire Sage Therapeutics for $795 million all cash
- Novo Nordisk’s amycretin drug helps obese adults lose 24% weight
- Wegovy’s weight-loss efficacy improves with higher dosage
- UK health agency, Met Office, issues an amber alert as temperatures rise
- Gilead’s Yeztugo drug for HIV prevention in adults gets FDA nod
- Eli Lilly to buy Verve for $1.3 billion, expands heart therapy segment
- US to review trials to stop genetic data misuse by China, ‘hostile’ nations
- Treat ghosts who lure men to their demise as a guide, and not a villain
- US regulator gives nod for Moderna’s expanded use of mRNA vaccine
Research
